Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Total Liabilities (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Total Liabilities for 4 consecutive years, with $51.5 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 19.12% to $51.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.5 million through Dec 2025, up 19.12% year-over-year, with the annual reading at $51.5 million for FY2025, 19.12% up from the prior year.
  • Total Liabilities for Q4 2025 was $51.5 million at Orchestra BioMed Holdings, down from $61.1 million in the prior quarter.
  • The five-year high for Total Liabilities was $61.1 million in Q3 2025, with the low at $5.9 million in Q1 2022.
  • Average Total Liabilities over 4 years is $32.7 million, with a median of $36.5 million recorded in 2023.
  • Peak annual rise in Total Liabilities hit 518.43% in 2023, while the deepest fall reached 36.87% in 2023.
  • Over 4 years, Total Liabilities stood at $43.0 million in 2022, then crashed by 36.87% to $27.2 million in 2023, then skyrocketed by 59.06% to $43.2 million in 2024, then grew by 19.12% to $51.5 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $51.5 million, $61.1 million, and $42.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.